株式会社グローバルインフォメーション
TEL: 044-952-0102
表紙
市場調査レポート

世界のデジタルPCR市場 - 成長、動向および予測

Digital PCR Market - Growth, Trends And Forecast (2020 - 2025)

発行 Mordor Intelligence LLP 商品コード 928067
出版日 ページ情報 英文 100 Pages
納期: 2-3営業日
価格
本日の銀行送金レート: 1USD=109.96円で換算しております。
世界のデジタルPCR市場 - 成長、動向および予測 Digital PCR Market - Growth, Trends And Forecast (2020 - 2025)
出版日: 2020年03月01日 ページ情報: 英文 100 Pages
担当者のコメント
下記の日本語概要は、最新版レポートの内容と異なる場合があります。詳細はお問合せください。
概要

当レポートでは、世界のデジタルPCR市場について調査しており、製品タイプ、技術、地域別の市場動向を分析・予測するとともに、市場成長の促進・阻害要因、投資分析、競合情勢、主要企業のプロファイルなどの情報提供しています。

目次

第1章 イントロダクション

第2章 調査方法

第3章 エグゼクティブサマリー

第4章 市場力学

  • 市場概況
  • 市場成長要因
  • 市場の阻害要因
  • ポーターのファイブフォース分析

第5章 市場セグメンテーション

  • 製品タイプ別
    • デジタルPCR機器
    • 消耗品と試薬
    • ソフトウェアとサービス
  • 技術別
    • ddPCR
    • BEAMingデジタルPCR
  • 用途別
    • 臨床診断
    • 法医学
    • 研究
    • その他
  • 地域別
    • 北米
    • 欧州
    • アジア太平洋地域
    • 中東・アフリカ地域
    • 南米

第6章 競合情勢

  • 会社概要
    • Bio-Rad Laboratories, Inc.
    • Thermo Fisher Scientific Inc
    • RainDance Technologies Inc.
    • Fluidigm Corporation
    • JN Medsys
    • QIAGEN
    • Merck KGaA
    • Stilla
    • Avance Biosciences

第7章 市場機会および将来動向

目次
Product Code: 68358

The Digital PCR market is projected to grow with a CAGR of nearly 17.8% over the forecast period. The major factor attributing to the growth of the market is the rising diagnostics and screening test of diseases like cancer, hereditary and infectious diseases, and growing demand for parental testing and gene study. As per GLOBOCAN, the number of leukemia cases in the year 2018 were around 437,033. As the incidence of such diseases increase, the usage of the Digital PCR increases and thus the market growth. Furthermore, technological advancements in the field of biotechnology and the increasing funding towards the same is boosting the market growth. However, high cost of the instruments and the lack of skilled labor is the major drawback for the market growth.

Key Market Trends

Droplet Digital PCR Segment to Dominate the Market Globally

Droplet Digital PCR (ddPCR) is a method for performing digital PCR that is based on water-oil emulsion droplet technology. A sample is fractionated into 20,000 droplets, and PCR amplification of the template molecules occur in each individual droplet. ddPCR technology uses reagents and workflows similar to those used for most standard TaqMan probe-based assays. The massive sample partitioning is a key aspect of the ddPCR technique. Apart from the above mentioned advantages of the ddPCR the factor that are propelling the segment growth are increasing prevalence of cancer, infectious diseases etc and increasing funding and advancements of biotechnology sector.

North America Dominates the Market and Expected to do Same in the Forecast Period

North America is expected to dominate the overall market, throughout the forecast period. The market growth is due to the factors such as the presence of key players, high prevalence of chronic diseases in the region and established healthcare infrastructure. Furthermore, beneficial government initiatives and increase in number of research partnerships are some of the drivers expected to increase the market growth. In this region the United States has the maximum share due to supportive healthcare policies, high number of patients, and a developed healthcare market.

Competitive Landscape

The Digital PCR market is moderately competitive and consists of several major players. Some of the companies which are currently dominating the market are Bio-Rad Laboratories, Inc., Thermo Fisher Scientific, RainDance Technologies Inc., Fluidigm Corporation, JN Medsys, QIAGEN, Merck KGaA, Stilla, Avance Biosciences.

Reasons to Purchase this report:

  • The market estimate (ME) sheet in Excel format
  • Report customization as per the client's requirements
  • 3 months of analyst support

Table of Contents

1. INTRODUCTION

  • 1.1. Study Deliverables
  • 1.2. Study Assumptions
  • 1.3. Scope of the Study

2. RESEARCH METHODOLOGY

3. EXECUTIVE SUMMARY

4. MARKET DYNAMICS

  • 4.1. Market Overview
  • 4.2. Market Drivers
    • 4.2.1. Rise in Prevalence of Infectious Diseases and Cancer
    • 4.2.2. Technological Advancements in the Field of Biotechnology
  • 4.3. Market Restraints
    • 4.3.1. High Cost of Digital PCR Devices
    • 4.3.2. Lack of Technical Expertise to Operate the Instrument
  • 4.4. Porter's Five Force Analysis
    • 4.4.1. Threat of New Entrants
    • 4.4.2. Bargaining Power of Buyers/Consumers
    • 4.4.3. Bargaining Power of Suppliers
    • 4.4.4. Threat of Substitute Products
    • 4.4.5. Intensity of Competitive Rivalry

5. MARKET SEGMENTATION

  • 5.1. By Product Type
    • 5.1.1. Digital PCR Equipment
    • 5.1.2. Consumables and Reagents
    • 5.1.3. Software and Services
  • 5.2. By Technology
    • 5.2.1. Droplet Digital PCR
    • 5.2.2. BEAMing Digital PCR
  • 5.3. By Application
    • 5.3.1. Clinical Diagnostics
    • 5.3.2. Forensics
    • 5.3.3. Research
    • 5.3.4. Others
  • 5.4. Geography
    • 5.4.1. North America
      • 5.4.1.1. United States
      • 5.4.1.2. Canada
      • 5.4.1.3. Mexico
    • 5.4.2. Europe
      • 5.4.2.1. Germany
      • 5.4.2.2. United Kingdom
      • 5.4.2.3. France
      • 5.4.2.4. Italy
      • 5.4.2.5. Spain
      • 5.4.2.6. Rest of Europe
    • 5.4.3. Asia-Pacific
      • 5.4.3.1. China
      • 5.4.3.2. Japan
      • 5.4.3.3. India
      • 5.4.3.4. Australia
      • 5.4.3.5. South Korea
      • 5.4.3.6. Rest of Asia-Pacific
    • 5.4.4. Middle-East and Africa
      • 5.4.4.1. GCC
      • 5.4.4.2. South Africa
      • 5.4.4.3. Rest of Middle-East and Africa
    • 5.4.5. South America
      • 5.4.5.1. Brazil
      • 5.4.5.2. Argentina
      • 5.4.5.3. Rest of South America

6. COMPETITIVE LANDSCAPE

  • 6.1. Company Profiles
    • 6.1.1. Bio-Rad Laboratories, Inc.
    • 6.1.2. Thermo Fisher Scientific Inc
    • 6.1.3. RainDance Technologies Inc.
    • 6.1.4. Fluidigm Corporation
    • 6.1.5. JN Medsys
    • 6.1.6. QIAGEN
    • 6.1.7. Merck KGaA
    • 6.1.8. Stilla
    • 6.1.9. Avance Biosciences

7. MARKET OPPORTUNITIES AND FUTURE TRENDS